Supernus Pharmaceuticals
About
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals is an award-winning biopharmaceutical company with over 30 years of experience in developing and commercializing products to treat central nervous system (CNS) diseases. They offer novel products designed to provide important health benefits to patients living with CNS diseases and are actively engaged in research and development of promising product candidates.
What is Supernus Pharmaceuticals's revenue?
StartupHub estimates Supernus Pharmaceuticals's annual revenue at $104.6M (range $56.3M to $280.5M, 68% confidence), based on comparable companies in the sector.
What is Supernus Pharmaceuticals's valuation?
StartupHub estimates Supernus Pharmaceuticals's effective valuation at $12.6B (range $4.6B to $23.0B, 43% confidence), based on comparable companies in the sector.
How much funding has Supernus Pharmaceuticals raised?
Supernus Pharmaceuticals has raised a total of $18M in funding. The most recent round on record is Series A.
Where is Supernus Pharmaceuticals headquartered?
Supernus Pharmaceuticals is headquartered in Rockville, United States.
When was Supernus Pharmaceuticals founded?
Supernus Pharmaceuticals was founded in 2005.
What industry does Supernus Pharmaceuticals operate in?
Supernus Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Healthcare, Neuroscience.
How many employees does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals has approximately 809 people on record.
No comments yet. Be the first to share your take.